Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy
EP Havranek,
K Nademanee,
PA Grayburn,
and
EJ Eichhorn
Section of Cardiology, Denver General Hospital, Colorado 80204, USA.
OBJECTIVES: This study sought to assess endothelium-dependent vasorelaxation in long-term users of cocaine. BACKGROUND: Cocaine use has been associated with myocardial infarction, stroke and intestinal infarction. Previously demonstrated effects of the drug, including increased heart rate and blood pressure and increased vascular tone, do not explain the sporadic nature of these vascular events or the occurrence of ischemia remote from acute administration. Abnormal endothelial function could contribute to focal vasospasm and thrombosis and predispose to premature atherosclerosis, all of which have been demonstrated in cocaine users with myocardial infarction. METHODS: Using plethysmography, we studied the change in forearm blood flow in response to intraarterial acetylcholine and nitroprusside in 10 long-term cocaine users and 13 control subjects of similar age who had not used cocaine; sample size was based on a 70% power to detect a 20% reduction in flow with acetylcholine between subjects and control subjects. Using graded doses of intracoronary acetylcholine (from 10(-9) to 10(-6) mol/liter), we studied a second group of 10 cocaine users with angiographically normal or near-normal arteries. RESULTS: Mean forearm blood flow during acetylcholine infusion was significantly lower in cocaine users than in control subjects (p = 0.02). During nitroprusside infusion, there was no difference (p = 0.2) between cocaine users and control subjects. Cigarette smoking did not explain the differences between cocaine users and control subjects. Acetylcholine elicited coronary vasoconstriction in 8 of 10 subjects. CONCLUSIONS: We conclude that endothelium-dependent vasorelaxation is impaired in long-term users of cocaine.
This article has been cited by other articles:

|
 |

|
 |
 
B. G. Schwartz, S. Rezkalla, and R. A. Kloner
Cardiovascular Effects of Cocaine
Circulation,
December 14, 2010;
122(24):
2558 - 2569.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Hoskins, R. M. Leleiko, J. J. Ramos, S. Sola, P. M. Caneer, and B. V. Khan
Effects of Labetalol on Hemodynamic Parameters and Soluble Biomarkers of Inflammation in Acute Coronary Syndrome in Patients With Active Cocaine Use
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2010;
15(1):
47 - 52.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Solages, J. A. Vita, D. J. Thornton, J. Murray, T. Heeren, D. E. Craven, and C. R. Horsburgh Jr.
Endothelial Function in HIV-Infected Persons
Clinical Infectious Diseases,
May 1, 2006;
42(9):
1325 - 1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. He, S. Yang, and L. Zhang
Effects of Cocaine on Nitric Oxide Production in Bovine Coronary Artery Endothelial Cells
J. Pharmacol. Exp. Ther.,
September 1, 2005;
314(3):
980 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pradhan, P. A. Dabisch, J. T. Liles, K. C. Agrawal, and P. J. Kadowitz
Effect of Acute Intravenous Cocaine Administration on Endothelium-Dependent Vasodepressor Responses to Acetylcholine
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2003;
8(1):
43 - 51.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Marder and I. K. Mellinghoff
Cocaine and Buerger Disease: Is There a Pathogenetic Association?
Arch Intern Med,
July 10, 2000;
160(13):
2057 - 2060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bartzokis, I. B. Goldstein, D. B. Hance, M. Beckson, D. Shapiro, P. H. Lu, N. Edwards, J. Mintz, and P. Bridge
The Incidence of T2-Weighted MR Imaging Signal Abnormalities in the Brain of Cocaine-Dependent Patients Is Age-Related and Region-Specific
AJNR Am. J. Neuroradiol.,
October 1, 1999;
20(9):
1628 - 1635.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
U. Wilbert-Lampen, C. Seliger, T. Zilker, and R. M. Arendt
Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine : Reversal by Coincubation With {sigma}-Receptor Antagonists
Circulation,
August 4, 1998;
98(5):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|